SkinHealth Systems Inc. Basic Shares Outstanding (Weighted Average)
SkinHealth Systems Inc. (SKIN) reported Basic Shares Outstanding (Weighted Average) of 129.60 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- SkinHealth Systems Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 129.60M shares, a 2.80% increase year-over-year.
- SkinHealth Systems Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 127.79M shares, a 2.17% increase year-over-year.
- SkinHealth Systems Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 127.45M shares, a 2.44% increase year-over-year.
- SkinHealth Systems Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 126.89M shares, a 2.28% increase year-over-year.
- SkinHealth Systems Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 126.38M shares, a 2.06% increase from fiscal 2024.
- SkinHealth Systems Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 123.83M shares, a 5.96% decline from fiscal 2023.
- SkinHealth Systems Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 131.68M shares, a 10.76% decline from fiscal 2022.
- SkinHealth Systems Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 147.55M shares, a 44.50% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 129.60M shares 10-Q · filed 2026-08-06 | 128.70M shares 10-Q · filed 2026-08-06 | 128.28M shares derived: average of 3 quarters · filed 2026-08-06 | 127.93M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 127.79M shares 10-Q · filed 2026-05-07 | 127.62M shares derived: average of 2 quarters · filed 2026-05-07 | 127.38M shares derived: average of 3 quarters · filed 2026-05-07 | 127.05M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 127.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 127.17M shares derived: average of 2 quarters · filed 2026-03-12 | 126.80M shares derived: average of 3 quarters · filed 2026-08-06 | 126.38M shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 126.89M shares 10-Q · filed 2025-11-06 | 126.48M shares derived: average of 2 quarters · filed 2026-08-06 | 126.02M shares 10-Q · filed 2025-11-06 | 125.62M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 126.07M shares 10-Q · filed 2026-08-06 | 125.58M shares 10-Q · filed 2026-08-06 | 125.19M shares derived: average of 3 quarters · filed 2026-08-06 | 124.91M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 125.08M shares 10-Q · filed 2026-05-07 | 124.75M shares derived: average of 2 quarters · filed 2026-05-07 | 124.52M shares derived: average of 3 quarters · filed 2026-05-07 | 124.32M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 124.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 124.24M shares derived: average of 2 quarters · filed 2026-03-12 | 124.06M shares derived: average of 3 quarters · filed 2026-03-12 | 123.83M shares 10-K · filed 2026-03-12 |
| 2024-09-30 | 124.06M shares 10-Q · filed 2025-11-06 | 123.89M shares derived: average of 2 quarters · filed 2025-11-06 | 123.63M shares 10-Q · filed 2025-11-06 | 124.90M shares derived: average of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | 123.72M shares 10-Q · filed 2025-08-07 | 123.42M shares 10-Q · filed 2025-08-07 | 125.17M shares derived: average of 3 quarters · filed 2026-03-12 | 127.10M shares derived: average of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | 123.12M shares 10-Q · filed 2025-05-08 | 125.90M shares derived: average of 2 quarters · filed 2026-03-12 | 128.23M shares derived: average of 3 quarters · filed 2026-03-12 | 129.35M shares derived: average of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | 128.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 130.79M shares derived: average of 2 quarters · filed 2026-03-12 | 131.43M shares derived: average of 3 quarters · filed 2026-03-12 | 131.68M shares 10-K · filed 2026-03-12 |
| 2023-09-30 | 132.90M shares 10-Q · filed 2024-11-12 | 132.81M shares derived: average of 2 quarters · filed 2024-11-12 | 132.68M shares 10-Q · filed 2024-11-12 | 134.03M shares derived: average of 4 quarters · filed 2025-03-12 |
| 2023-06-30 | 132.72M shares 10-Q · filed 2024-08-08 | 132.57M shares 10-Q · filed 2024-08-08 | 134.41M shares derived: average of 3 quarters · filed 2025-03-12 | 138.51M shares derived: average of 4 quarters · filed 2025-03-12 |
| 2023-03-31 | 132.42M shares 10-Q · filed 2024-05-09 | 135.26M shares derived: average of 2 quarters · filed 2025-03-12 | 140.44M shares derived: average of 3 quarters · filed 2025-03-12 | 143.01M shares derived: average of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | 138.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | 144.44M shares derived: average of 2 quarters · filed 2025-03-12 | 146.54M shares derived: average of 3 quarters · filed 2025-03-12 | 147.55M shares 10-K · filed 2025-03-12 |
| 2022-09-30 | 150.79M shares 10-Q · filed 2023-11-14 | 150.76M shares derived: average of 2 quarters · filed 2023-11-14 | 150.71M shares 10-Q · filed 2023-11-14 | 149.73M shares derived: average of 4 quarters · filed 2024-03-12 |
| 2022-06-30 | 150.73M shares 10-Q · filed 2023-08-09 | 150.67M shares 10-Q · filed 2023-08-09 | 149.38M shares derived: average of 3 quarters · filed 2024-03-12 | 145.11M shares derived: average of 4 quarters · filed 2024-03-12 |
| 2022-03-31 | 150.60M shares 10-Q · filed 2023-05-10 | 148.70M shares derived: average of 2 quarters · filed 2024-03-12 | 143.24M shares derived: average of 3 quarters · filed 2024-03-12 | 130.38M shares derived: average of 4 quarters · filed 2024-03-12 |
| 2021-12-31 | 146.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | 139.55M shares derived: average of 2 quarters · filed 2024-03-12 | 123.64M shares derived: average of 3 quarters · filed 2024-03-12 | 102.11M shares 10-K · filed 2024-03-12 |
| 2021-09-30 | 132.31M shares 10-Q · filed 2022-11-09 | 112.05M shares derived: average of 2 quarters · filed 2022-11-09 | 87.22M shares 10-Q · filed 2022-11-09 | 73.79M shares derived: average of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | 91.80M shares 10-Q · filed 2022-08-09 | 63.81M shares 10-Q · filed 2022-08-09 | 54.29M shares derived: average of 3 quarters · filed 2023-03-01 | 49.56M shares derived: average of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | 35.50M shares 10-Q · filed 2022-05-10 | 35.53M shares derived: average of 2 quarters · filed 2023-03-01 | 35.48M shares derived: average of 3 quarters · filed 2023-03-01 | 35.23M shares derived: average of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | 35.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 35.48M shares derived: average of 2 quarters · filed 2023-03-01 | 35.14M shares derived: average of 3 quarters · filed 2023-03-01 | 34.29M shares 10-K · filed 2023-03-01 |
| 2020-09-30 | 35.39M shares 10-Q · filed 2021-11-12 | 34.94M shares derived: average of 2 quarters · filed 2021-11-12 | 33.87M shares 10-Q · filed 2021-11-12 | |
| 2020-06-30 | 34.48M shares 10-Q · filed 2021-08-13 | 33.31M shares 10-Q · filed 2021-08-13 | ||
| 2019-12-31 | 32.14M shares 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |